Haemophagocytic lymphohistiocytosis in an infant: Important aspects in management

Hong Kong Journal of Paediatrics

Volumn 12, Issue 3, 2007, Pages

  Hui, W H ^a,b   Ng, D K K ^a   Kwok, K L ^a   Lam, Y Y ^a  

^a KWONG WAH HOSPITAL   (Hong Kong)

^b Caritas Medical Centre Hong Kong   (Hong Kong)

Author keywords

Haemophagocytic lymphohistiocytosis; Infant; Intravenous immunoglobulin; Management

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; IMMUNOGLOBULIN; PREDNISOLONE; STEROID;

ARTICLE; CASE REPORT; CLINICAL FEATURE; CYTOPENIA; DISEASE SEVERITY; DRUG EFFICACY; DRUG SUBSTITUTION; FEMALE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HEPATOSPLENOMEGALY; HUMAN; INFANT; LUMBAR PUNCTURE; NATURAL KILLER CELL; OPPORTUNISTIC INFECTION; PROGNOSIS; REMISSION; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 34447526749     PISSN: 10139923     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hemophagocytic lymphohistiocytosis Study Group. Histiocyte Society. Treatment protocol of the Second International HLH Study 2004 (HLH-2004).
2. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29-33.
3. Janka GE, Schneider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004;124:4-14.
4. Henter JI, Elinder G, Soder O, Ost A. Incidence in Sweden and clinical features of familial hemophagocytic lymphohistiocytosis. Acta Paediatr Scand 1991;80:428-35.
5. Tiab M, Mechinaud F, Harousseau JL. Haemophagocytic syndrome associated with infections. Baillieres Best Pract Res Clin Haematol 2000;13:163-78.
6. Stéphan JL, Koné-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) 2001;40:1285-92.
7. Horne A, Zheng C, Lorenz I, et al. Subtyping of natural killer cell cytotoxicity deficiencies in haemophagocytic lymphohistocytosis provides therapeutic guidance. Br J Haematol 2005;129:658-66.
8. Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001;114:761-9.
9. Hallahan AR, Carpenter PA, O'Gorman-Hughes DW, Vowels MR, Marshall GM. Haemophagocytic lymphohistiocytosis in children. J Paediatr Child Health 1999;35:55-9.
10. Chen RL, Lin KH, Lin DT, et al. Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol 1995;89:282-90.
11. Henter JI, Samuelsson-Horne A, Arico M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002;100:2367-73.
12. Filipovich AH. Life-threatening hemophagocytic syndromes: current outcomes with hematopoietic stem cell transplantation. Pediatr Transplant 2005;9 Suppl 7:87-91.
13. Aricò M, Janka G, Fischer A, et al. Hemophagocytic lymphohistiocytosis. Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society. Leukemia 1996;10:197-203.
14. Imashuku S, Kuriyama K, Teramura T, et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001;19:2665-73.
15. Imashuku S, Teramura T, Morimoto A, Hibi S. Recent developments in the management of haemophagocytic lymphohistiocytosis. Expert Opin Pharmacother 2001;2:1437-48.
16. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12):435-44.
17. Gill DS, Spencer A, Cobcroft RG. High-dose gammaglobulin therapy in the reactive haemophagocytic syndrome. Br J Haematol 1994;88:204-6.
18. Imashuku S, Hibi S, Ohara T, et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphogamma histiocytosis with immunochemotherapy. Histiocyte Society. Blood 1999;93:1869-74.
19. Chen JS, Lin KH, Lin DT, Chen RL, Jou ST, Su IJ. Longitudinal observation and outcome of nonfamilial childhood haemophagocytic syndrome receiving etoposide-gamma containing regimens. Br J Haematol 1998;103:756-62.
20. Chen RL, Lin KH, Lin DT, et al. Immunomodulation treatment for childhood virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol 1995;89:282-90.